MCLE Medicale Corp.

Fundamentals / CIK 0001827855 / USD

Medicale Corp. reported $0 in total assets and a net loss of $30K through September 30, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open MCLE in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

5 fiscal years (2021 to 2025), reported in USD.

$0$0$0-$54KFY 2021 Revenue: $0FY 2021 Net Income: -$32K2021FY 2022 Revenue: $0FY 2022 Net Income: -$46K2022FY 2023 Net Income: -$37K2023FY 2024 Net Income: -$58K2024FY 2025 Net Income: -$41K2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Sep 30 Sep 30 Sep 30 Sep 30 Sep 30
Revenue -- -- -- $0 $0
Total Operating Expenses $33K $55K $38K $44K $32K
Operating Income -$33K -$55K -$38K -$44K -$32K
Interest Expense $7.5K $3.5K $0 -- --
Income Before Tax -- -$58K -$38K -$44K -$32K
Income Tax Expense $0 $0 $0 $0 $0
Net Income -$41K -$58K -$37K -$46K -$32K
Basic EPS -$0.01 -$0.01 -$0.01 -$0.01 -$0.01
Diluted EPS -$0.01 -$0.01 -$0.01 -$0.01 -$0.01
Basic Shares Outstanding 5.9M 5.9M 5.9M 5.9M 3.6M
Diluted Shares Outstanding 5.9M 5.9M 5.9M 5.9M 3.6M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Total Operating Expenses $3.1K $8.7K $3.6K $6.3K $15K $16K $9.3K $11K
Operating Income -$3.1K -$8.7K -$3.6K -$6.3K -$15K -$16K -$9.3K -$11K
Interest Expense $2.1K $2.0K $2.0K $1.8K $1.7K -- -- --
Income Before Tax -- -- -- -- -- -$17K -$10K -$12K
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$5.3K -$11K -$5.5K -$8.3K -$17K -$17K -$10K -$12K
Basic EPS $0.00 -- $0.00 $0.00 $0.00 -- $0.00 $0.00
Diluted EPS $0.00 -- $0.00 $0.00 $0.00 -- $0.00 $0.00
Basic Shares Outstanding 5.9M -- 5.9M 5.9M 5.9M -- 5.9M 5.9M
Diluted Shares Outstanding 5.9M -- 5.9M 5.9M 5.9M -- 5.9M 5.9M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30
Cash & Cash Equivalents $0 $159 $159 $0 $18K $0
Cash & Short-Term Investments $0 $159 $159 $0 $18K $0
Accounts Receivable, Net -- -- -- -- -- $0
Total Current Assets $0 $159 $159 $0 $19K $200
Intangible Assets -- -- $0 $0 $9.6K $12K
Total Non-Current Assets $0 $0 $0 $0 $9.6K $12K
Total Assets $0 $159 $159 $0 $28K $12K
Accounts Payable -- $0 -- -- -- $12K
Short-Term Debt -- -- -- -- -- $1.0K
Total Current Liabilities $34K $16K $41K $55K $37K $14K
Total Non-Current Liabilities $106K $84K $0 $0 $0 $0
Total Liabilities $140K $99K $41K $55K $37K $14K
Total Debt (incl. Leases) -- -- -- -- -- $1.0K
Common Stock $592 $592 $592 $592 $592 $340
Retained Earnings -$217K -$176K -$118K -$80K -$34K -$1.9K
Total Stockholders' Equity -$140K -$99K -$41K -$55K -$8.4K -$1.4K
Total Equity -$140K -$99K -$41K -$55K -$8.4K -$1.4K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Cash & Cash Equivalents -- $0 -- -- $159 $159 $159 $159
Cash & Short-Term Investments -- $0 -- -- $159 $159 $159 $159
Total Current Assets $0 $0 $0 $0 $159 $159 $159 $159
Intangible Assets -- -- -- -- -- -- $0 $0
Total Non-Current Assets $0 $0 $0 $0 $0 $0 $0 $0
Total Assets $0 $0 $0 $0 $159 $159 $159 $159
Accounts Payable -- -- -- -- $995 $0 -- --
Total Current Liabilities $32K $34K $29K $26K $18K $16K $14K $13K
Total Non-Current Liabilities $113K $106K $100K $98K $94K $84K $68K $59K
Total Liabilities $145K $140K $129K $124K $112K $99K $82K $72K
Common Stock $592 $592 $592 $592 $592 $592 $592 $592
Retained Earnings -$222K -$217K -$206K -$201K -$189K -$176K -$159K -$149K
Total Stockholders' Equity -$145K -$140K -$129K -$124K -$116K -$99K -$82K -$72K
Total Equity -$145K -$140K -$129K -$124K -$116K -$99K -$82K -$72K

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Sep 30 Sep 30 Sep 30 Sep 30 Sep 30
Net Income -$41K -$58K -$37K -$46K -$32K
Change in Payables $11K -$4.9K -- -- --
Operating Cash Flow -$23K -$84K -$26K -$25K -$18K
Investing Cash Flow -- $0 $0 $0 $0
Common Stock Issued -- -- -- $0 $25K
Financing Cash Flow $23K $84K $26K $6.1K $36K
Net Change in Cash -$159 $0 $159 -$18K $18K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Net Income -$5.3K -$11K -$5.5K -$8.3K -$17K -$17K -$10K -$12K
Change in Payables -$3.6K $2.2K $1.6K $1.9K $5.0K $1.4K $1.2K $962
Operating Cash Flow -$6.7K -$6.5K -$2.0K -$4.5K -$10K -$16K -$9.3K -$31K
Financing Cash Flow $6.7K $6.5K $2.0K $4.4K $10K $16K $9.3K $31K
Net Change in Cash $0 $0 $0 -$159 $0 $0 $0 $0

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Sep 30 Sep 30 Sep 30 Sep 30 Sep 30
Return on Assets (ROA) -- -36611.9% -23357.2% -- -113.7%
Current Ratio 0.00x 0.01x 0.00x 0.00x 0.51x
Quick Ratio 0.00x 0.01x 0.00x 0.00x 0.50x

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Return on Assets (ROA) -- -- -- -- -34959.7% -36611.9% -34942.8% -33732.7%
Current Ratio 0.00x 0.00x 0.00x 0.00x 0.01x 0.01x 0.01x 0.01x
Quick Ratio -- 0.00x -- -- 0.01x 0.01x 0.01x 0.01x
Source: SEC EDGAR CompanyFacts (CIK 0001827855) · from December 31, 2018 Data through December 31, 2025 · synced Nov 21, 2026, 05:16 UTC · Open in terminal